1. Home
  2. BGX vs CSBR Comparison

BGX vs CSBR Comparison

Compare BGX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGX
  • CSBR
  • Stock Information
  • Founded
  • BGX 2010
  • CSBR 1985
  • Country
  • BGX United States
  • CSBR United States
  • Employees
  • BGX N/A
  • CSBR N/A
  • Industry
  • BGX Trusts Except Educational Religious and Charitable
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BGX Finance
  • CSBR Health Care
  • Exchange
  • BGX Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • BGX 157.8M
  • CSBR 135.5M
  • IPO Year
  • BGX N/A
  • CSBR 1986
  • Fundamental
  • Price
  • BGX $12.40
  • CSBR $9.11
  • Analyst Decision
  • BGX
  • CSBR Strong Buy
  • Analyst Count
  • BGX 0
  • CSBR 1
  • Target Price
  • BGX N/A
  • CSBR $12.00
  • AVG Volume (30 Days)
  • BGX 67.9K
  • CSBR 42.8K
  • Earning Date
  • BGX 01-01-0001
  • CSBR 03-11-2025
  • Dividend Yield
  • BGX 10.34%
  • CSBR N/A
  • EPS Growth
  • BGX N/A
  • CSBR N/A
  • EPS
  • BGX N/A
  • CSBR 0.46
  • Revenue
  • BGX N/A
  • CSBR $58,591,000.00
  • Revenue This Year
  • BGX N/A
  • CSBR $14.19
  • Revenue Next Year
  • BGX N/A
  • CSBR $10.11
  • P/E Ratio
  • BGX N/A
  • CSBR $20.77
  • Revenue Growth
  • BGX N/A
  • CSBR 19.03
  • 52 Week Low
  • BGX $10.69
  • CSBR $3.60
  • 52 Week High
  • BGX $12.44
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • BGX 40.53
  • CSBR 43.32
  • Support Level
  • BGX $12.28
  • CSBR $9.21
  • Resistance Level
  • BGX $12.46
  • CSBR $9.97
  • Average True Range (ATR)
  • BGX 0.12
  • CSBR 0.73
  • MACD
  • BGX 0.01
  • CSBR -0.04
  • Stochastic Oscillator
  • BGX 33.33
  • CSBR 30.91

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategy in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first- and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: